Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026
← Back to Research Index
Compare Evaluate Matrix Half-Life
Dossier · № 104 of 110 Updated Nov 17, 2026

Glow

GLOW blend · GHK-Cu + BPC-157 + TB-500 · skin + tissue repair blend

ANECDOTAL · THREE-COMPONENT REGENERATIVE BLEND (MATRIKINE + CYTOPROTECTIVE + ACTIN-REGULATOR)

Mechanism of action

Layered remodelling: GHK-Cu's copper-peptide matrikine signal upregulates collagen and elastin transcription and engages roughly 4,000 wound-healing genes; BPC-157 drives angiogenesis via VEGFR2 and stabilises epithelial / connective-tissue repair; TB-500 sequesters G-actin to enable cell migration and amplifies stem-cell mobilisation. Together: matrix synthesis + vessel-bed repair + cell-migration substrate.

Researched effects

Skin regeneration; injury and wound recovery; collagen and elastin synthesis support; dermal remodelling; commonly the entry-point recovery blend before stepping up to Klow (which adds an anti-inflammatory arm)

Dosing reported in literature

Typical SC protocols deliver ~250-500 mcg per component daily for 4-6 week loading cycles. Confirm per-component dose from the vial total before reconstitution

Known concerns

No human trials of the combined formulation; TB-500 WADA-banned with theoretical pro-proliferative concerns; chronic GHK-Cu raises copper-accumulation considerations at high doses; injection-site reactions

Continue reading